Compare Stocks → Urgent: Protect Your Investments from a Chinese Invasion (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:ASNDCVE:CDBTSE:MAW Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASNDAscendis Pharma A/S$151.17+1.8%$145.24$64.33▼$161.00$8.72B0.52388,281 shs295,863 shsCDBCordoba MineralsC$0.37-3.9%C$0.39C$0.27▼C$0.55C$33.20M0.9318,125 shs72,806 shsMAWMawson GoldC$0.35C$0.14▼C$0.42C$101.97M1.5123,442 shs101,500 shs10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASNDAscendis Pharma A/S-1.01%+2.92%-5.78%+16.55%+35.29%CDBCordoba Minerals-1.28%-3.75%-1.28%+11.59%-15.38%MAWMawson Gold0.00%0.00%0.00%-4.17%+53.33%This consistently signaled gains of 453%... 610%... and even 1036%... (Ad)It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASNDAscendis Pharma A/S0.8616 of 5 stars2.42.00.00.02.21.70.6CDBCordoba MineralsN/AN/AN/AN/AN/AN/AN/AN/AMAWMawson GoldN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASNDAscendis Pharma A/S2.70Moderate Buy$174.1415.20% UpsideCDBCordoba MineralsN/AN/AN/AN/AMAWMawson GoldN/AN/AN/AN/ACurrent Analyst RatingsLatest ASND, CDB, MAW, WRES, and AQC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/15/2024ASNDAscendis Pharma A/SWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$196.00 ➝ $260.002/8/2024ASNDAscendis Pharma A/SCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$146.00 ➝ $182.002/8/2024ASNDAscendis Pharma A/SWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$207.00 ➝ $225.002/6/2024ASNDAscendis Pharma A/SCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$152.00 ➝ $173.001/8/2024ASNDAscendis Pharma A/SWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform$202.00 ➝ $207.00(Data available from 3/28/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASNDAscendis Pharma A/S$288.08M30.28N/AN/A($2.73) per share-55.37CDBCordoba MineralsN/AN/AC$0.02 per share19.05C$0.33 per shareN/AMAWMawson GoldN/AN/AN/A5.15C$0.20 per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASNDAscendis Pharma A/S-$521.07M-$9.25N/AN/AN/A-180.61%-16,574.15%-55.10%4/25/2024 (Estimated)CDBCordoba Minerals-C$30.36M-C$0.37N/A∞N/AN/A-180.38%-67.71%N/AMAWMawson Gold-C$6.23M-C$0.02N/AN/AN/AN/A-12.43%-5.89%N/ALatest ASND, CDB, MAW, WRES, and AQC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/7/2024Q4 2023ASNDAscendis Pharma A/S-$2.15-$1.66+$0.49-$1.66$97.02 million$148.62 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASNDAscendis Pharma A/SN/AN/AN/AN/AN/ACDBCordoba MineralsN/AN/AN/AN/AN/AMAWMawson GoldN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASNDAscendis Pharma A/S7.393.562.50CDBCordoba Minerals2.334.210.11MAWMawson Gold1.125.7913.85OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASNDAscendis Pharma A/SN/ACDBCordoba Minerals0.19%MAWMawson Gold32.55%Insider OwnershipCompanyInsider OwnershipASNDAscendis Pharma A/S40.00%CDBCordoba Minerals82.69%MAWMawson Gold1.28%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableASNDAscendis Pharma A/S87957.71 million34.62 millionOptionableCDBCordoba MineralsN/A89.73 millionN/ANot OptionableMAWMawson Gold8295.57 millionN/ANot OptionableASND, CDB, MAW, WRES, and AQC HeadlinesSourceHeadlineGeelong local footy: 24 things to watch out for in 2024goldcoastbulletin.com.au - March 28 at 4:41 PMBruce John Griffin Sells 369,000 Shares of Mawson Gold Limited (TSE:MAW) Stockamericanbankingnews.com - March 22 at 7:02 AMMawson subsidiary SXG to dual list in Canadaminingweekly.com - March 13 at 7:57 AMSouthern Cross Gold eyes Canada for dual listing in rare movemining.com - March 12 at 8:48 PMMawson Gold Limited: Mawson's Subsidiary SXG Announces Intention to Dual List in Canadafinanznachrichten.de - March 12 at 3:47 PMAdelaide Airbnb hosts hoping to capitalise on 2024 AFL Gather Round by listing properties for the extended weekendgoldcoastbulletin.com.au - March 11 at 6:33 PMPolice charge Mawson Lakes man over Hilton Vet Clinic blaze and attempted arson at O’Halloran Hillgoldcoastbulletin.com.au - March 8 at 11:05 AMMawson Gold Limited: Mawson's Subsidiary SXG Drills 2,318 g/t Gold Over 1.0 m in Best Hole at Sunday Creekfinanznachrichten.de - March 5 at 8:39 AMCanadian Investment Regulatory Organization Trade Resumption - MAWfinance.yahoo.com - March 5 at 8:39 AMCanadian Investment Regulatory Organization Trading Halt - MAWfinance.yahoo.com - March 4 at 12:37 PMGovernment asks the now-closed McLaren Vale Hospital for $1.1mgoldcoastbulletin.com.au - March 1 at 9:11 PMWest Yorkshire Victorian village is Unesco Gem and must-visit spot for award-winning beersexpress.co.uk - February 23 at 1:35 AMWhy China has just built its fifth base in Antarcticagoldcoastbulletin.com.au - February 19 at 6:12 PMPeople Revealed The Creepiest, Cult-Like Towns Across The United States, And Personally, I'd Take Note Of Theseyahoo.com - February 19 at 6:12 PMMawson Gold Limitedbaystreet.ca - February 12 at 1:54 PMSeeing the last huskies on Mawson left expeditioner speechless on first trip to continentgoldcoastbulletin.com.au - February 12 at 8:54 AMMawson’s Subsidiary SXG Provides Geological Update for the Sunday Creek Projectfinance.yahoo.com - January 23 at 9:02 AMASTL Jan 2024 11.000 callca.finance.yahoo.com - December 31 at 2:27 PMASTL Jan 2024 10.000 putca.finance.yahoo.com - December 24 at 7:30 PMMawson Announces Listing on TSX Venture Exchange and Corporate Updatefinance.yahoo.com - December 21 at 8:18 AMMawson Gold Limited: SXG Drills 9.3 m @ 94.9 g/t Goldfinanznachrichten.de - December 14 at 2:06 PMSXG Drills 9.3 m @ 94.9 g/t Gold (Uncut)finance.yahoo.com - December 14 at 2:06 PMMawson Receives Support for All Resolutions at the Annual General and Special Meeting and Reminds Investors the Pro-Rata Financing for Finland is Now Openfinance.yahoo.com - December 7 at 6:43 PMMawson Gold Limited: Mawson's Subsidiary SXG Drills 3.1 Metres @ 20.6 g/t Gold Extends Mineralization 250 Metres Westfinanznachrichten.de - November 30 at 9:30 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsAscendis Pharma A/SNASDAQ:ASNDAscendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.Cordoba MineralsCVE:CDBCordoba Minerals Corp., a mineral exploration company, engages in the acquisition, exploration, evaluation, and development of base and precious metal properties in Colombia and the United States. The company explores for copper, silver, and gold deposits. It primarily holds a 100% interest in the San Matias project with exploration licenses covering 146.62 square kilometers and has an additional 893.91 square kilometers of mining titles under application located in the municipality of Puerto Libertador, Department of Cordoba, Colombia. The company was incorporated in 2009 and is headquartered in Vancouver, Canada.Mawson GoldTSE:MAWMawson Gold Limited operates as a gold exploration company in Finland and Sweden. The company also explores for cobalt, copper, lead, zinc, and silver deposits. Its flagship project is the Rompas-Rajapalot project that consists of 5 granted exploration permits and 8 exploration permit applications located in Finland. The company was formerly known as Mawson Resources Limited and changed its name to Mawson Gold Limited in August 2020. Mawson Gold Limited was incorporated in 2004 and is headquartered in Vancouver, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.